Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1393174 | 0.83 | ALDH1A1 (0.31) | — | |
| SCHEMBL1393071 | 0.83 | — | — | |
| SCHEMBL1393197 | 0.79 | — | — | |
| SCHEMBL396335 | 0.79 | CYP3A4 (0.41) | CYP3A4 | |
| SCHEMBL2460965 | 0.72 | CYP2A6 (0.34) | — | |
| SCHEMBL5089395 | 0.65 | — | — | |
| SCHEMBL5089492 | 0.65 | CD44 (0.33) | CYP3A4 | |
| SCHEMBL19047834 | 0.58 | — | — | |
| SCHEMBL260747 | 0.58 | — | — | |
| SCHEMBL11030089 | 0.58 | TP53 (0.43) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8480926-B2 | Liquid-crystalline compound and organic semiconductor device containing the compound | JNC CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20120007062-A1 | NOVEL LIQUID-CRYSTALLINE COMPOUND AND ORGANIC SEMICONDUCTOR DEVICE CONTAINING THE COMPOUND | JNC CORPORATION (JP) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120007062-A1 | NOVEL LIQUID-CRYSTALLINE COMPOUND AND ORGANIC SEMICONDUCTOR DEVICE CONTAINING THE COMPOUND | ARNT, SLCO2A1, CRY2 | CYP3A4 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.